Procter & Gamble Health Ltd (PGHL):企業の財務・戦略的SWOT分析

◆英語タイトル:Procter & Gamble Health Ltd (PGHL) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDCPG81840FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年2月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Consumer Packaged Goods
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥33,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥49,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Procter & Gamble Health Ltd (PGHL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Procter & Gamble Health Ltd (P&G Health), formerly Merck Ltd, a subsidiary of Procter & Gamble Overseas India BV, is a manufacturer and marketer of pharmaceutical products. The company’s product portfolio comprises over-the-counter products, minerals, vitamins and supplements products for consumers. It markets products under Neurobion, Polybion, Evion, Livogen, Nasivion, and Seven Seas brand names. The company manufactures its pharma and chemical products at the company-owned production facility in Goa, India and third-party managed production sites. It exports pharmaceutical products to Asian countries such as Nepal, Maldives, Myanmar and Sri Lanka; and outside Asia. P&G Health is headquartered in Mumbai, Maharashtra, India.

Procter & Gamble Health Ltd Key Recent Developments

May 29,2020: Procter & Gamble Health posts net profit of Rs 46.5 crore for March quarter
Jan 13,2020: P&G Health partners with PHFI to implement Digital Health Project at Goa under its ‘SEHAT’ CSR Program

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Procter & Gamble Health Ltd – Key Facts
Procter & Gamble Health Ltd – Key Employees
Procter & Gamble Health Ltd – Major Products and Services
Procter & Gamble Health Ltd – History
Procter & Gamble Health Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Procter & Gamble Health Ltd – Business Description
Other Break-up: Other operating revenue
Performance
Other Break-up: Sale of products
Performance
Geographical Segment: India
Performance
Geographical Segment: Outside India
Performance
Procter & Gamble Health Ltd – SWOT Analysis
SWOT Analysis – Overview
Procter & Gamble Health Ltd – Strengths
Procter & Gamble Health Ltd – Weaknesses
Procter & Gamble Health Ltd – Opportunities
Procter & Gamble Health Ltd – Threats
Procter & Gamble Health Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Procter & Gamble Health Ltd, Recent Deals Summary
Section 4 – Company’s Recent Developments
May 29, 2020: Procter & Gamble Health posts net profit of Rs 46.5 crore for March quarter
Jan 13, 2020: P&G Health partners with PHFI to implement Digital Health Project at Goa under its ‘SEHAT’ CSR Program
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Procter & Gamble Health Ltd, Key Facts
Procter & Gamble Health Ltd, Key Employees
Procter & Gamble Health Ltd, Major Products and Services
Procter & Gamble Health Ltd, History
Procter & Gamble Health Ltd, Other Locations
Procter & Gamble Health Ltd, Key Competitors
Procter & Gamble Health Ltd, Ratios based on current share price
Procter & Gamble Health Ltd, Annual Ratios
Procter & Gamble Health Ltd, Annual Ratios (Cont...1)
Procter & Gamble Health Ltd, Annual Ratios (Cont...2)
Procter & Gamble Health Ltd, Interim Ratios
Procter & Gamble Health Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Procter & Gamble Health Ltd (PGHL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fiskars Corp (FSKRS):企業の財務・戦略的SWOT分析
    Fiskars Corp (FSKRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Innopharmax Inc (4172):製薬・医療:M&Aディール及び事業提携情報
    Summary Innopharmax Inc (InnoPharmax), a subsidiary of Synmosa Biopharma Corp is a pharmaceutical company that develops and commercializes products for the treatment of oncology and specialty. The company provides anti-infection agents, oncology agents, contrast agents, immunological agents and drug …
  • Samsung Securities Co Ltd (016360):企業の財務・戦略的SWOT分析
    Samsung Securities Co Ltd (016360) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Saudi Arabian Mining Co:企業の戦略・SWOT・財務情報
    Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report Summary Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Northern Trust Corporation:企業のM&A・事業提携・投資動向
    Northern Trust Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Northern Trust Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Trent Limited (TRENT):企業の財務・戦略的SWOT分析
    Trent Limited (TRENT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • UTair Aviation:企業の戦略・SWOT・財務情報
    UTair Aviation - Strategy, SWOT and Corporate Finance Report Summary UTair Aviation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Metgasco Ltd (MEL):石油・ガス:M&Aディール及び事業提携情報
    Summary Metgasco Ltd (Metgasco) is an oil and gas exploration company. The company that acquires, explores, produces, and develops oil and gas, petroleum and hydrocarbon assets. It holds interests in Clarence Moreton Basin, an exploration license located in northern New South Wales. Metgasco supplie …
  • Raschig GmbH:企業の戦略的SWOT分析
    Raschig GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Hydro-Electric Corporation:企業の戦略的SWOT分析
    Hydro-Electric Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • CardioComm Solutions Inc (EKG):企業の製品パイプライン分析
    Summary CardioComm Solutions Inc (CardioComm) is a medical technology company that offers software solutions for information management systems in cardiovascular medicine and telemedicine. It offers software engineering of computer based electrocardiogram management and reporting software. Its produ …
  • Grohe AG:企業の戦略的SWOT分析
    Grohe AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)-製薬・医療分野:企業M&A・提携分析
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) manufactures and markets traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, western medicines, dietary supplements, pharmaceutical raw materials an …
  • GS Yuasa Corporation (6674):企業の財務・戦略的SWOT分析
    GS Yuasa Corporation (6674) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Shanghai SECCO Petrochemical Co Ltd:企業の戦略的SWOT分析
    Shanghai SECCO Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Citigroup Inc:企業の戦略・SWOT・財務情報
    Citigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Citigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ImpediMed Ltd (IPD):製品パイプライン分析
    Summary ImpediMed Ltd (ImpediMed) is a manufacturer of bioimpedance devices with a focus on medical applications in the fluid status domain. It designs, manufactures and sells bioimpedance spectroscopy (BIS) devices for assessing lymphoedema and body composition. The major products of the company in …
  • GeNeuro SA (GNRO):企業の財務・戦略的SWOT分析
    Summary GeNeuro SA (GeNeuro) operates as a clinical stage pharmaceutical company that manufactures therapeutic product pipeline for disorders of the nervous system. The company provides treatments against inflammatory and degenerative disorders associated with endogenous retroviruses. GeNeuro develo …
  • The Boston Beer Company, Inc. (SAM):企業の財務・戦略的SWOT分析
    The Boston Beer Company, Inc. (SAM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lohmann & Rauscher GmbH & Co. KG:企業の戦略的SWOT分析
    Lohmann & Rauscher GmbH & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆